Survival Benefits of Neoadjuvant Immunochemotherapy Versus Chemotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma: A Propensity Matched Score
{{output}}
Background: While neoadjuvant chemotherapy (NCT) and neoadjuvant immunochemotherapy (NICT) are effective treatments for locally advanced esophageal squamous cell carcinoma (ESCC), comparative analyses of their long-term survival ... ...
